JP2024533315A5 - - Google Patents

Info

Publication number
JP2024533315A5
JP2024533315A5 JP2024515071A JP2024515071A JP2024533315A5 JP 2024533315 A5 JP2024533315 A5 JP 2024533315A5 JP 2024515071 A JP2024515071 A JP 2024515071A JP 2024515071 A JP2024515071 A JP 2024515071A JP 2024533315 A5 JP2024533315 A5 JP 2024533315A5
Authority
JP
Japan
Prior art keywords
sequence
mutation
grna
gene
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024515071A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024533315A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/076058 external-priority patent/WO2023039435A2/en
Publication of JP2024533315A publication Critical patent/JP2024533315A/ja
Publication of JP2024533315A5 publication Critical patent/JP2024533315A5/ja
Pending legal-status Critical Current

Links

JP2024515071A 2021-09-08 2022-09-07 Pah調節性組成物及び方法 Pending JP2024533315A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163241897P 2021-09-08 2021-09-08
US63/241,897 2021-09-08
US202263303927P 2022-01-27 2022-01-27
US63/303,927 2022-01-27
US202263367025P 2022-06-24 2022-06-24
US63/367,025 2022-06-24
PCT/US2022/076058 WO2023039435A2 (en) 2021-09-08 2022-09-07 Pah-modulating compositions and methods

Publications (2)

Publication Number Publication Date
JP2024533315A JP2024533315A (ja) 2024-09-12
JP2024533315A5 true JP2024533315A5 (cg-RX-API-DMAC7.html) 2025-09-17

Family

ID=85506900

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024515071A Pending JP2024533315A (ja) 2021-09-08 2022-09-07 Pah調節性組成物及び方法

Country Status (9)

Country Link
US (1) US12544458B2 (cg-RX-API-DMAC7.html)
EP (1) EP4399306A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024533315A (cg-RX-API-DMAC7.html)
KR (1) KR20240099164A (cg-RX-API-DMAC7.html)
AU (1) AU2022342168A1 (cg-RX-API-DMAC7.html)
CA (1) CA3231712A1 (cg-RX-API-DMAC7.html)
IL (1) IL311218A (cg-RX-API-DMAC7.html)
TW (1) TW202320810A (cg-RX-API-DMAC7.html)
WO (1) WO2023039435A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019327449B2 (en) 2018-08-28 2026-04-09 Flagship Pioneering Innovations Vi, Llc Methods and compositions for modulating a genome
IL296095A (en) 2020-03-04 2022-11-01 Flagship Pioneering Innovations Vi Llc Improved methods and compositions for genome modulation
BR112022017715A2 (pt) 2020-03-04 2022-11-16 Flagship Pioneering Innovations Vi Llc Métodos e composições para modular um genoma
KR20260037664A (ko) 2021-09-08 2026-03-18 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 게놈을 조절하기 위한 방법 및 조성물
CA3231712A1 (en) 2021-09-08 2023-03-16 Flagship Pioneering Innovations Vi, Llc Pah-modulating compositions and methods
IL312965A (en) * 2021-11-24 2024-07-01 Flagship Pioneering Innovations Vi Llc Immunogenic compositions and their uses
EP4444362A4 (en) 2021-12-10 2026-04-01 Flagship Pioneering Innovations Vi Llc CFTR COMPOSITIONS AND MODULATION METHODS
EP4684023A2 (en) * 2023-03-21 2026-01-28 Tessera Therapeutics, Inc. Modified template guide rna molecules
US20250059567A1 (en) * 2023-08-17 2025-02-20 The Trustees Of The University Of Pennsylvania Compositions and methods for the management and treatment of phenylketonuria
WO2026123006A1 (en) * 2024-12-06 2026-06-11 Tessera Therapeutics, Inc. Pah-modifying compositions and methods

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11120889B2 (en) * 2012-05-09 2021-09-14 Georgia Tech Research Corporation Method for synthesizing a nuclease with reduced off-site cleavage
CN111218447B (zh) 2013-11-07 2024-10-11 爱迪塔斯医药有限公司 使用统治型gRNA的CRISPR相关方法和组合物
WO2018013558A1 (en) * 2016-07-12 2018-01-18 Life Technologies Corporation Compositions and methods for detecting nucleic acid regions
WO2019040650A1 (en) 2017-08-23 2019-02-28 The General Hospital Corporation GENETICALLY MODIFIED CRISPR-CAS9 NUCLEASES HAVING MODIFIED PAM SPECIFICITY
CN107723358B (zh) * 2017-10-26 2021-03-19 国家卫生健康委科学技术研究所 苯丙酮尿症检测试剂盒
CA3104989A1 (en) * 2018-03-27 2019-10-03 G+Flas Life Sciences Sequence-specific in vivo cell targeting
US20210261957A1 (en) * 2018-07-10 2021-08-26 Alia Therapeutics S.R.L. Vesicles for traceless delivery of guide rna molecules and/or guide rna molecule/rna-guided nuclease complex(es) and a production method thereof
AU2019327449B2 (en) 2018-08-28 2026-04-09 Flagship Pioneering Innovations Vi, Llc Methods and compositions for modulating a genome
CN113272428A (zh) * 2018-10-18 2021-08-17 英特利亚治疗股份有限公司 核酸构建体和使用方法
WO2020191241A1 (en) * 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
CA3147875A1 (en) 2019-07-19 2021-01-28 Flagship Pioneering Innovations Vi, Llc Recombinase compositions and methods of use
EP4034659A4 (en) 2019-09-27 2024-10-16 The Broad Institute, Inc. PROGRAMMABLE POLYNUCLEOTIDE EDITORS FOR AMPLIFIED HOMOLOGOUS RECOMBINATION
EP4061940A4 (en) 2019-11-22 2024-10-23 Flagship Pioneering Innovations VI, LLC RECOMBINASE COMPOSITIONS AND METHODS OF USE
WO2021138469A1 (en) 2019-12-30 2021-07-08 The Broad Institute, Inc. Genome editing using reverse transcriptase enabled and fully active crispr complexes
BR112022017715A2 (pt) 2020-03-04 2022-11-16 Flagship Pioneering Innovations Vi Llc Métodos e composições para modular um genoma
AU2021232005A1 (en) 2020-03-04 2022-09-29 Flagship Pioneering Innovations Vi, Llc Methods and compositions for modulating a genome
US20230348939A1 (en) 2020-03-04 2023-11-02 Flagship Pioneering Innovations Vi, Llc Methods and compositions for modulating a genome
IL296095A (en) 2020-03-04 2022-11-01 Flagship Pioneering Innovations Vi Llc Improved methods and compositions for genome modulation
BR112022017735A2 (pt) 2020-03-05 2022-11-29 Flagship Pioneering Innovations Vi Llc Métodos e composições de supressão de defesa de hospedeiro para modular um genoma
CA3177481A1 (en) 2020-05-08 2021-11-11 David R. Liu Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
TW202208632A (zh) * 2020-05-27 2022-03-01 美商同源醫藥公司 用於恢復pah基因功能的腺相關病毒組成物及其使用方法
WO2021248102A1 (en) 2020-06-05 2021-12-09 Flagship Pioneering Innovations Vi, Llc Template guide rna molecules
AU2022206476A1 (en) 2021-01-11 2023-07-20 President And Fellows Of Harvard College Prime editor variants, constructs, and methods for enhancing prime editing efficiency and precision
US20240132916A1 (en) 2021-02-09 2024-04-25 The Broad Institute, Inc. Nuclease-guided non-ltr retrotransposons and uses thereof
WO2022183210A1 (en) 2021-02-26 2022-09-01 Flagship Pioneering Innovations Vi, Llc Tissue-specific methods and compositions for modulating a genome
AU2022240747A1 (en) 2021-03-19 2023-10-05 Flagship Pioneering Innovations Vi, Llc Ltr transposon compositions and methods
EP4314257A4 (en) 2021-04-01 2025-07-09 Prime Medicine Inc METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES
EP4347859A4 (en) 2021-05-26 2025-07-02 Flagship Pioneering Innovations Vi Llc INTEGRASE COMPOSITIONS AND METHODS
EP4352230A4 (en) 2021-06-03 2025-06-11 Prime Medicine, Inc. Genome editing compositions and methods for treating Wilson's disease
WO2023283092A1 (en) 2021-07-06 2023-01-12 Prime Medicine, Inc. Compositions and methods for efficient genome editing
WO2023004439A2 (en) 2021-07-23 2023-01-26 Prime Medicine, Inc. Genome editing compositions and methods for treatment of chronic granulomatous disease
WO2023015318A2 (en) 2021-08-05 2023-02-09 Prime Medicine, Inc. Genome editing compositions and methods for treatment of cystic fibrosis
AU2022325166A1 (en) 2021-08-06 2024-02-08 President And Fellows Of Harvard College Improved prime editors and methods of use
CA3231712A1 (en) 2021-09-08 2023-03-16 Flagship Pioneering Innovations Vi, Llc Pah-modulating compositions and methods
KR20260037664A (ko) 2021-09-08 2026-03-18 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 게놈을 조절하기 위한 방법 및 조성물
MX2024002930A (es) 2021-09-08 2024-05-29 Flagship Pioneering Innovations Vi Llc Metodos y composiciones para modular un genoma.
WO2023039447A2 (en) 2021-09-08 2023-03-16 Flagship Pioneering Innovations Vi, Llc Serpina-modulating compositions and methods
EP4399307A4 (en) 2021-09-08 2026-01-21 Flagship Pioneering Innovations Vi Llc HBB COMPOSITIONS AND MODULATION METHODS
CA3235826A1 (en) 2021-10-21 2023-04-27 Wei Hsi Yeh Genome editing compositions and methods for treatment of usher syndrome type 3
US20250011766A1 (en) 2021-11-09 2025-01-09 Prime Medicine, Inc. Genome Editing Compositions and Methods for Treatment of Amyotrophic Lateral Sclerosis
US20250319202A1 (en) 2021-11-09 2025-10-16 Prime Medicine, Inc. Genome editing compositions and methods for treatment of fuchs endothelial corneal dystrophy
EP4430189A1 (en) 2021-11-11 2024-09-18 Prime Medicine, Inc. Genome editing compositions and methods for treatment of fragile x syndrome
US20250297248A1 (en) 2021-11-24 2025-09-25 Prime Medicine, Inc. Methods and compositions for inhibiting mismatch repair
AU2022398241A1 (en) 2021-11-24 2024-06-06 Prime Medicine, Inc. Modified prime editing guide rnas
EP4444362A4 (en) 2021-12-10 2026-04-01 Flagship Pioneering Innovations Vi Llc CFTR COMPOSITIONS AND MODULATION METHODS
WO2023192655A2 (en) 2022-04-01 2023-10-05 Prime Medicine, Inc. Methods and compositions for editing nucleotide sequences

Similar Documents

Publication Publication Date Title
JP2024533313A5 (cg-RX-API-DMAC7.html)
JP2024533312A5 (cg-RX-API-DMAC7.html)
US12565649B2 (en) Methods of rescuing stop codons via genetic reassignment with ACE-tRNA
EP4399292A2 (en) Methods and compositions for modulating a genome
JP2024533311A5 (cg-RX-API-DMAC7.html)
JPH10503644A (ja) 新規な内部リボソーム侵入部位、これを含むベクター、および治療への使用
JP2016539629A (ja) レトロウイルスベクター
JPH10500852A (ja) 遺伝子治療のための安全なベクター
CN115210366A (zh) 工程化环状指导rna
WO2022170058A1 (en) Prime editor system for in vivo genome editing
US20260125673A1 (en) Artificial polynucleotides for expressing proteins
JPH06343477A (ja) 医薬的および診断的使用のための組み換えフオーミーウイルスベクター、および組み換えフオーミーウイルスベクターの作製方法
WO2023205694A2 (en) Stabilization of therapeutic trans-splicing rna molecules in human cells
JPH10507628A (ja) 非自己不活化性の発現標的化レトロウイルスベクタ
EP4605530A2 (en) Improved gene editing systems utilizing trans recruiting components
KR102876548B1 (ko) Francisella novicida Cas9 모듈 기반의 역전사 효소를 사용한 유전체 치환 및 삽입 기술
AU2022343271A1 (en) Recruitment in trans of gene editing system components
IL323066A (en) PAH Modulating Systems and Methods
JP2002519069A (ja) レトロウイルスベクターを用いた染色体へのターゲッティングされた組込み
JP2002508338A (ja) レンチウィルスベクターの治療使用
JP2026509461A (ja) Serpina調節性組成物及び方法
JPH11502706A (ja) シュードタイプレトロウイルス粒子
JPH0253491A (ja) ベクター及びその利用方法
RU2801848C1 (ru) Генетическая конструкция, адаптированная для доставки гена SMN1 человека с помощью аденоассоциированного вируса серотипа 2 для обеспечения нейроспецифичной экспрессии
JP2026515056A (ja) 合成核酸及びその治療的使用